The Europe Thyroid Ablation Devices Market should witness market growth of 12.6% CAGR during the forecast period (2022-2028).
Procedures for thyroid ablation are effective because they potentially carry fewer risks,are less invasive, preserve more thyroid tissue, and aid patients in maintaining normal thyroid function. Radiation exposure is known to raise the risk of developing thyroid cancer. The International Agency for Research on Cancer (IARC) has discovered that having thyroid cancer increases the risk of being overweight or obese. Follicular thyroid carcinoma is more common in areas with poor iodine consumption.
However, iodine-rich food may increase the likelihood of papillary thyroid cancer. More ablation operations are being performed as thyroid cancer incidence rises. In addition,thyroid nodules areon the rise, and they are one of the more common endocrine system illnesses. Therefore, the development of the thyroid ablation devices market is also predicted to be boostedby the introduction ofadvanced ablation techniques.
Differentiated thyroid cancer (DTC) has been steadily increasing over the past few decades in Europe, with estimates for male and female populations of 3and 9cases per 100,000 person-years, respectively. Even though there are epidemiological variations between nations, papillary thyroid cancer (PTC) accounts for 80-85% of instances, follicular cancer for roughly 5%-10%, and medullary and anaplastic cancer for the remainder. Since the mortality rate for this disease is low, most DTCs are not considered to beaggressive tumors. This is further propelling the growth of the thyroid ablation devices market in the coming years.
The Germany market dominated the Europe Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $19,172.8 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 11.6% during (2022-2028). Additionally, The France market would exhibit a CAGR of 13.4% during (2022-2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Procedures for thyroid ablation are effective because they potentially carry fewer risks,are less invasive, preserve more thyroid tissue, and aid patients in maintaining normal thyroid function. Radiation exposure is known to raise the risk of developing thyroid cancer. The International Agency for Research on Cancer (IARC) has discovered that having thyroid cancer increases the risk of being overweight or obese. Follicular thyroid carcinoma is more common in areas with poor iodine consumption.
However, iodine-rich food may increase the likelihood of papillary thyroid cancer. More ablation operations are being performed as thyroid cancer incidence rises. In addition,thyroid nodules areon the rise, and they are one of the more common endocrine system illnesses. Therefore, the development of the thyroid ablation devices market is also predicted to be boostedby the introduction ofadvanced ablation techniques.
Differentiated thyroid cancer (DTC) has been steadily increasing over the past few decades in Europe, with estimates for male and female populations of 3and 9cases per 100,000 person-years, respectively. Even though there are epidemiological variations between nations, papillary thyroid cancer (PTC) accounts for 80-85% of instances, follicular cancer for roughly 5%-10%, and medullary and anaplastic cancer for the remainder. Since the mortality rate for this disease is low, most DTCs are not considered to beaggressive tumors. This is further propelling the growth of the thyroid ablation devices market in the coming years.
The Germany market dominated the Europe Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $19,172.8 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 11.6% during (2022-2028). Additionally, The France market would exhibit a CAGR of 13.4% during (2022-2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Scope of the Study
By End-use
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cancer Specialty Centers
- Others
By Type
- Radiofrequency Ablation
- Microwave Ablation
- Others
By Application
- Thyroid Cancer
- Thyroid Nodules
By Product
- Thermal-based Devices
- Non-thermal-based Devices
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Thyroid Ablation Devices Market, by End-use
1.4.2 Europe Thyroid Ablation Devices Market, by Type
1.4.3 Europe Thyroid Ablation Devices Market, by Application
1.4.4 Europe Thyroid Ablation Devices Market, by Product
1.4.5 Europe Thyroid Ablation Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Thyroid Ablation Devices Market by End-use
3.1 Europe Hospitals Market by Country
3.2 Europe Ambulatory Surgical Centers (ASCs) Market by Country
3.3 Europe Cancer Specialty Centers Market by Country
3.4 Europe Others Market by Country
Chapter 4. Europe Thyroid Ablation Devices Market by Type
4.1 Europe Radiofrequency Ablation Market by Country
4.2 Europe Microwave Ablation Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Thyroid Ablation Devices Market by Application
5.1 Europe Thyroid Cancer Market by Country
5.2 Europe Thyroid Nodules Market by Country
Chapter 6. Europe Thyroid Ablation Devices Market by Product
6.1 Europe Thermal-based Devices Market by Country
6.2 Europe Non-thermal-based Devices Market by Country
Chapter 7. Europe Thyroid Ablation Devices Market by Country
7.1 Germany Thyroid Ablation Devices Market
7.1.1 Germany Thyroid Ablation Devices Market by End-use
7.1.2 Germany Thyroid Ablation Devices Market by Type
7.1.3 Germany Thyroid Ablation Devices Market by Application
7.1.4 Germany Thyroid Ablation Devices Market by Product
7.2 UK Thyroid Ablation Devices Market
7.2.1 UK Thyroid Ablation Devices Market by End-use
7.2.2 UK Thyroid Ablation Devices Market by Type
7.2.3 UK Thyroid Ablation Devices Market by Application
7.2.4 UK Thyroid Ablation Devices Market by Product
7.3 France Thyroid Ablation Devices Market
7.3.1 France Thyroid Ablation Devices Market by End-use
7.3.2 France Thyroid Ablation Devices Market by Type
7.3.3 France Thyroid Ablation Devices Market by Application
7.3.4 France Thyroid Ablation Devices Market by Product
7.4 Russia Thyroid Ablation Devices Market
7.4.1 Russia Thyroid Ablation Devices Market by End-use
7.4.2 Russia Thyroid Ablation Devices Market by Type
7.4.3 Russia Thyroid Ablation Devices Market by Application
7.4.4 Russia Thyroid Ablation Devices Market by Product
7.5 Spain Thyroid Ablation Devices Market
7.5.1 Spain Thyroid Ablation Devices Market by End-use
7.5.2 Spain Thyroid Ablation Devices Market by Type
7.5.3 Spain Thyroid Ablation Devices Market by Application
7.5.4 Spain Thyroid Ablation Devices Market by Product
7.6 Italy Thyroid Ablation Devices Market
7.6.1 Italy Thyroid Ablation Devices Market by End-use
7.6.2 Italy Thyroid Ablation Devices Market by Type
7.6.3 Italy Thyroid Ablation Devices Market by Application
7.6.4 Italy Thyroid Ablation Devices Market by Product
7.7 Rest of Europe Thyroid Ablation Devices Market
7.7.1 Rest of Europe Thyroid Ablation Devices Market by End-use
7.7.2 Rest of Europe Thyroid Ablation Devices Market by Type
7.7.3 Rest of Europe Thyroid Ablation Devices Market by Application
7.7.4 Rest of Europe Thyroid Ablation Devices Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Boston Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Integra LifeSciences Holdings Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Johnson & Johnson
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental &Regional Analysis
8.4.4 Research & Development Expenses
8.5 Theraclion SA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Olympus Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Regional Analysis
8.8 BVM Medical Limited
8.8.1 Company Overview
8.9 MedWaves, Inc.
8.9.1 Company Overview
8.10. STARmed Co. Ltd.
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Methodology
LOADING...
